|
| 1 |
Treatment after failure of frontline therapy of chronic myeloid leukemia in chronic phase including allogeneic hematopoietic stem cell transplantation
Jieun Uhm
Blood Res.2023;58(S1):S109-S113. Published online 2023 April 30
DOI: http://dx.doi.org/10.5045/br.2023.2023054
|
|
| 2 |
Implications of the 5th Edition of the World Health Organization Classification and International Consensus Classification of Myeloid Neoplasm in Myelodysplastic Syndrome With Excess Blasts and Acute Myeloid Leukemia
Cheonghwa Lee, Ha Nui Kim, Jung Ah Kwon, Soo-Young Yoon, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Chul Won Choi, Jung Yoon
Ann Lab Med.2023;43(5):503-507. Published online 2023 April 21
DOI: http://dx.doi.org/10.3343/alm.2023.43.5.503
|
|
| 3 |
Treatment-free remission after discontinuation of imatinib, dasatinib, and nilotinib in patients with chronic myeloid leukemia
Jae Joon Han
Blood Res.2023;58(S1):S58-S65. Published online 2023 April 7
DOI: http://dx.doi.org/10.5045/br.2023.2023035
|
|
| 4 |
Asciminib: the first-in-class allosteric inhibitor of BCR::ABL1 kinase
Eun-Ji Choi
Blood Res.2023;58(S1):S29-S36. Published online 2023 March 9
DOI: http://dx.doi.org/10.5045/br.2023.2023017
|
|
| 5 |
Measurable Residual Disease Testing Using Next-Generation Sequencing in Acute Myeloid Leukemia
Seon Young Kim, Hee Jin Huh
Ann Lab Med.2023;43(4):323-324. Published online 2023 February 24
DOI: http://dx.doi.org/10.3343/alm.2023.43.4.323
|
|
| 6 |
Development of a Next-generation Sequencing-based Gene Panel Test to Detect Measurable Residual Disease in Acute Myeloid Leukemia
Jin Ju Kim, Ji Eun Jang, Hyeon Ah Lee, Mi Ri Park, Hye Won Kook, Seung-Tae Lee, Jong Rak Choi, Yoo Hong Min, Saeam Shin, June-Won Cheong
Ann Lab Med.2023;43(4):328-336. Published online 2023 February 24
DOI: http://dx.doi.org/10.3343/alm.2023.43.4.328
|
|
| 7 |
The impact of COVID-19 on acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: a concise review
Reham Osama Mansour, Shaimaa El-Ashwah, May Denewer
Blood Res.2023;58(1):13-19. Published online 2023 February 8
DOI: http://dx.doi.org/10.5045/br.2023.2022144
|
|
| 8 |
Immunohistochemical Staining to Identify Concomitant Systemic Mastocytosis in Acute Myeloid Leukemia with RUNX1::RUNX1T1
Sang Mee Hwang, Beom Joon Kim, Jee-Soo Lee, Moon-Woo Seong, Soo Hyun Seo, Jin Ho Paik, Sang-A Kim, Ji Yun Lee, Jeong-Ok Lee, Yoon Hwan Chang, Soo Mee Bang
Ann Lab Med.2022;42(6):678-682. Published online 2022 November 1
DOI: http://dx.doi.org/10.3343/alm.2022.42.6.678
|
|
| 9 |
Overexpression of Prohibitin 2 Protein is Associated with Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia
Young Eun Lee, Ha Jin Lim, Ju Heon Park, Hye Ran Kim, Min-Gu Kang, Young Kuk Cho, Jong Hee Shin, Myung Geun Shin
Ann Lab Med.2022;42(5):585-589. Published online 2022 September 1
DOI: http://dx.doi.org/10.3343/alm.2022.42.5.585
|
|
| 10 |
Clinical and Genomic Profiles of Korean Patients with MECOM Rearrangement and the t(3;21)(q26.2;q22.1) Translocation
Jikyo Lee, Sung Min Kim, Soonok Kim, Jiwon Yun, Dajeong Jeong, Young Eun Lee, Eun-Youn Roh, Dong Soon Lee
Ann Lab Med.2022;42(5):590-596. Published online 2022 September 1
DOI: http://dx.doi.org/10.3343/alm.2022.42.5.590
|
|
| 11 |
골수형성이상증후군/급성골수성백혈병 환자에서 발견된 DDX41의 새로운 생식세포 돌연변이
Min-Sun Kwak, In Hwa Jeong, Sung-Hyun Kim, Namhee Kim
|
|
| 12 |
Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
Seo-Yeon Ahn, Sang Kyun Son, Gyu Hyung Lee, Inho Kim, June-Won Cheong, Won Sik Lee, Byung Soo Kim, Deog-Yeon Jo, Chul Won Jung, Chu Myoung Seong, Jae Hoon Lee, Young Jin Yuh, Min Kyoung Kim, Hun-Mo Ryoo, Moo-Rim Park, Su-Hee Cho, Hoon-Gu Kim, Dae Young Zang, Jinny Park, Hawk Kim, Seryeon Lee, Sung-Hyun Kim, Myung Hee Chang, Ho Sup Lee, Chul Won Choi, Jihyun Kwon, Sung-Nam Lim, Suk-Joong Oh, Inkyung Joo, Dong-Wook Kim
Blood Res.2022;57(2):144-151. Published online 2022 June 30
DOI: http://dx.doi.org/10.5045/br.2022.2021137
|
|
| 13 |
Chronic myeloid leukemia: a type of MPN
Muhammad Ammar Samad, Eman Mahboob, Hussain Mansoor
Blood Res.2022;57(2):95-100. Published online 2022 June 30
DOI: http://dx.doi.org/10.5045/br.2022.2021173
|
|
| 14 |
FLT3 mutations in acute myeloid leukemia: a review focusing on clinically applicable drugs
Jae-Sook Ahn, Hyeoung-Joon Kim
Blood Res.2022;57(S1):32-36. Published online 2022 April 30
DOI: http://dx.doi.org/10.5045/br.2022.2022017
|
|
| 15 |
Human acute myeloid leukemia stem cells: evolution of concept
Dong-Yeop Shin
Blood Res.2022;57(S1):67-74. Published online 2022 April 30
DOI: http://dx.doi.org/10.5045/br.2022.2021221
|
|
| 16 |
IDH1/2 mutations in acute myeloid leukemia
Ja Min Byun, Seung-Joo Yoo, Hyeong-Joon Kim, Jae-Sook Ahn, Youngil Koh, Jun Ho Jang, Sung-Soo Yoon
Blood Res.2022;57(1):13-19. Published online 2022 March 31
DOI: http://dx.doi.org/10.5045/br.2021.2021152
|
|
| 17 |
JAK2 V617F 양성 급성골수성백혈병의 임상병리학적 특징 2예
Youngeun Lee, Ji Yun Lee, Jeong-Ok Lee, Soo-Mee Bang, Sang Mee Hwang
|
|
| 18 |
A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities
Zahra Nekoukar, Minoo Moghimi, Ebrahim Salehifar
Blood Res.2021;56(4):229-242. Published online 2021 December 31
DOI: http://dx.doi.org/10.5045/br.2021.2021117
|
|
| 19 |
Outcome of Intensive Therapy for Children with Relapsed Acute Myeloid Leukemia: A Single Institution Korean Study
Jae Wook Lee, Jae Won Yoo, Seongkoo Kim, Pil-Sang Jang, Nack-Gyun Chung, Bin Cho
Cancer Res Treat.2022;54(4):1230-1239. Published online 2021 December 17
DOI: http://dx.doi.org/10.4143/crt.2021.1011
|
|
| 20 |
Granulocytic and Monocytic Myeloid-Derived Suppressor Cells are Functionally and Prognostically Different in Patients with Chronic Myeloid Leukemia
Ari Ahn, Chan-Jeoung Park, Min-sun Kim, Young-Uk Cho, Seongsoo Jang, Mi Hyun Bae, Jung-Hee Lee, Je-Hwan Lee, Kyung-Nam Koh, Ho Joon Im
Ann Lab Med.2021;41(5):479-484. Published online 2021 September 1
DOI: http://dx.doi.org/10.3343/alm.2021.41.5.479
|
|
